Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of Candida Species - Mann, Paul A.; McNicholas, Paul M.; Chau, Andrew S.; Patel, Reena; Mendrick, Cara; Ullmann, Andrew J.; Cornely, Oliver A.; Patino, Hernando; Black, Todd A. (Antimicrobial Agents and Chemotherapy, 2009)
Keywords: Adolescent; Adult; Aged; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antifungal Agents; Antifungal Agents - pharmacology; Antifungal Agents - therapeutic use; Biological and medical sciences; Candida; Candida - classification; Candida - drug effects; Candida - genetics; Candida albicans; Candida albicans - classification; Candida albicans - drug effects; Candida albicans - genetics; Candida albicans - pathogenicity; Candida glabrata - classification; Candida glabrata - drug effects; Candida glabrata - genetics; Candida glabrata - pathogenicity; Candidiasis - drug therapy; Candidiasis - microbiology; Clinical Therapeutics; Female; Fluconazole; Fluconazole - pharmacology; Fluconazole - therapeutic use; Humans; Itraconazole; Itraconazole - pharmacology; Itraconazole - therapeutic use; Male; Medical sciences; Microbial Sensitivity Tests; Middle Aged; Pharmacology. Drug treatments; Phylogeny; Saccharomyces; Triazoles; Triazoles - pharmacology; Triazoles - therapeutic use; Young Adult; Fungi; Infection; Candidiasis; Chemoprophylaxis; Sensitivity; Yeast; Mycosis; Candida; Azole derivatives; Fungi Imperfecti; Species; Colonization